Insider · CIK 0002027962
Stephen Basil Thomas
director
Files at CLYM (Climb Bio, Inc.). First filing Sep 17, 2026, latest Sep 17, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLYM: Climb Bio, Inc.
CLYMOct 9, 2026 · close 11.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Climb Bio, Inc. | $1.4M 100,000 shares | -18% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | CLYM Climb Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -100,000 | $13.67 | $1.4M | 467,969 | 25 d ago |
| Aug 7, 2025 | CLYM Climb Bio, Inc. | AGrant or award Common Stock | +100,375 | $0.00 | $0 | 304,657 | Aug 11, 2025 |
| Jun 27, 2025 | CLYM Climb Bio, Inc. | MOption exercise Common Stock | +25,094 | - | - | 204,282 | Jul 1, 2025 |
| Jun 27, 2025 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative | -25,094 | $0.00 | $0 | 0 | Jul 1, 2025 |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 5, 2025 |
| Mar 27, 2025 | CLYM Climb Bio, Inc. | MOption exercise Common Stock | +25,093 | - | - | 179,188 | Mar 27, 2025 |
| Mar 27, 2025 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative | -25,093 | $0.00 | $0 | 25,094 | Mar 27, 2025 |
| Jan 1, 2025 | CLYM Climb Bio, Inc. | MOption exercise Common Stock | +50,188 | - | - | 154,095 | Jan 3, 2025 |
| Jan 1, 2025 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative | -50,188 | $0.00 | $0 | 50,187 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.